What is the impact of weight-loss drugs on companies that make obesity treatments?
'Barron's Roundtable' panelists discuss the hefty cost of obesity drugs and its impact on Medicare benefits.
Main ingredient in over-the-counter decongestants ‘does not work at all’: Dr. Kevin Campbell
Cardiologist Dr. Kevin Campbell joined ‘Cavuto: Coast to Coast’ to react to a Federal Drug Administration panel’s argument that popular decongestants are ineffective.
Genelux develops next-generation immunotherapies for oncology patients
Genelux President and CEO Thomas Zindrick discusses promising cancer treatments on 'The Claman Countdown.'
AI won't replace your personalized workouts: 'You might be getting hurt,' trainer says
FOX Business' Madison Alworth explains how personal trainers and fitness professionals are hard to replace with A.I.
NYC Mayor Eric Adams issues stark warning: Migrant crisis could 'destroy' the city
FOX Business' Madison Alworth has the latest on the impact of migrants on the back-to-school process on 'Mornings with Maria.'
Americans want 'self-determination' when it comes to health choices: Rep. Richard McCormick
Rep. Richard McCormick, R-Ga., a member of the GOP doctors caucus, discusses White House COVID protocols and questions surrounding Mitch McConnell's health.
Sen. Ron Johnson: The government is a purveyor of misinformation
Sen. Ron Johnson, R-Wis., and Dr. Marty Makary react to allegations the CDC censored COVID-19 information on 'The Bottom Line.'
Cencora is central to healthcare economies: CEO Steven Collis
Cencora Chairman and President Steven Collis discusses the world of Big Pharma after the Biden administration named 10 high-cost drugs for Medicare price negotiations on 'The Claman Countdown.'
Rep. Buddy Carter rips Biden over naming drugs subject to Medicare price negotiation: 'Tone deaf'
Rep. Buddy Carter, R-Ga., discusses Hurricane Idalia, the Biden administration announcing drugs subject to Medicare price negotiation and Speaker McCarthy pushing a short-term spending bill.
ChatGPT plays doctor with a 72% success rate
Fox News medical contributor Dr. Marc Siegel discusses ChatGPT's accuracy in making medical decisions on 'The Big Money Show.'
AI is a 'beautiful tool' that helps streamline medical paperwork: Mark Michalski
Ascertain CEO Mark Michalski discusses how A.I. can enhance the doctor-patient process on 'The Claman Countdown.'
Revolutionary AI implants help paralyzed woman ‘talk’ for first time in nearly 20 years
FOX Business’ Lauren Simonetti reports on a fascinating medical breakthrough that was developed using artificial intelligence.
Delta launches new health technologies for in-flight medical emergencies: ‘As safe as possible’
To help ensure the safety of passengers, Delta Air Lines is rolling out upgrades to its onboard medical tools and technology. The chief health officer shared details.
New COVID variant could infect about 30% of US population: Dr. Marty Makary
John Hopkins Professor of Public Health Dr. Marty Makary discusses whether a new COVID strain is about to sweep the nation and if a booster shot is appropriate for everyone on 'Cavuto: Coast to Coast.'
Ford CEO admits 'reality check' during F-150 Lightning Route 66 road trip
'Fox & Friends Weekend' co-host Pete Hegseth and FOX Business' Lydia Hu join 'The Big Money Show' to discuss the pandemic learning loss for children and EV charging challenges.
Psychedelics show 'enormous promise' in mental health treatment: Robert Barrow
MindMed CEO Robert Barrow explains how psychedelic-inspired medicines could revolutionize treatment for mental health disorders on 'Varney & Co.'
Hims & Hers CEO Andrew Dudum launches weight management program
Hims & Hers Health CEO and co-founder Andrew Dudum discusses the telehealth company's weight loss platform on 'The Claman Countdown.'
Marijuana legalization is a 'huge mistake': Kevin Sabet
Former White House drug policy adviser Kevin Sabet argues that high-potency marijuana leads to an increase in mental illness and psychosis on 'Varney & Co.'
You can get a complete Barbie plastic surgery makeover for $120K
Long Island plastic surgeon Dr. Scott Blyer, a.k.a. 'Dr. B Fixin,' says his practice 'has been making Barbies for years.'
There's finally hope for patients with Alzheimer's disease: Lisa Ricciardi
Cognition Therapeutics President and CEO Lisa Ricciardi discusses the FDA considering the approval of a new Alzheimer's drug and the progress being made in the space to help combat the disease.